This week, I interview Scott Rabuka, Director of the Genomics Program at DNA Genotek. Scott joined DNA Genotek in 2008 as the product manager for Oragene and expanded the product into a family of solutions for genomic research and clinical use. He is responsible for the launch of the company's first FDA 510(k) cleared product in 2011 as well as multiple new products. Scott speaks about saliva as a DNA sample type, who’s using it today and how it compares to other sample typesb.

We recently had the opportunity to visit our sister company, Novosanis, in Antwerp, Belgium, to talk about urine as a sample type. Novosanis is dedicated to solving urine sampling challenges through its product Colli-Pee™ - an award-winning device designed to efficiently and hygienically capture first-void urine (the first 20ml of a urine sample). I spoke with their CEO and co-founder, Vanessa Vankerckhoven about the challenges first void urine collection solves for both cancer detection as...

We recently introduced listeners of Molecules, microbes and multiomics to our sister company, CoreBiome, a privately-held microbiome analysis company. We continue the story with CoreBiome co-founder, Dr. Dan Knights. In this podcast, Dr. Knights speaks to us about why the microbiome is so different from the human genome, what answers microbiome research can provide for wellness & disease that we can’t find elsewhere, and what advice he would give an epidemiologist who is adding microbiome...

In the podcast, Dr. Dan Knights, co-founder and CEO of CoreBiome discusses the problems CoreBiome was built to solve and the challenges surrounding reproducibility in the microbiome field. You’ll learn why he “geeks out” about quality, efficiency, and accuracy and how his team keeps CoreBiome at the forefront of the microbiome industry. Learn more about CoreBiome and what it can do for microbiome researchers and clinicians here.